Search
01/03/2026
Risk stratification tool for pharmaceutical care in patients with cardiovascular disease
Lopez, AD, Escrig, EV, Serrano, PS, Morillo-Verdugo, R. Risk stratification tool for pharmaceutical care in patients with cardiovascular disease. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.07.001. PMID:40877090. IF:(Q/D).
01/08/2021
Managing urticaria in the emergency department: recommendations of a multidisciplinary expert panel
Salvador, JFS, Gimenez-Arnau, AM, de la Fuente, EG, del Castillo, JG, Virto, AMM, Blanco, IM, Serra-Baldrich, E, Llorens, P. Managing urticaria in the emergency department: recommendations of a multidisciplinary expert panel. EMERGENCIAS. 2021; 33(4)DOI:. PMID:34251143. IF:5.345(Q1/2D).
01/10/2024
Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis
Augustin, M, Gottlieb, AB, Lebwohl, M, Pinter, A, Warren, RB, Puig, L, Warham, R, Lambert, J, Wiegratz, S, Szilagyi, B, Blauvelt, A. Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis. Dermatology and Therapy. 2024; 14(10)DOI:10.1007/s13555-024-01261-6. PMID:39285121. IF:4.200(Q1/1D).
01/01/2024
Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan
Tada, Y, Soliman, AM, Ishii, K, Sakuma, R, Puig, L, Davis, M, Nunag, D, Pinter, A, Imafuku, S. Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan. Dermatology and Therapy. 2024; 14(1)DOI:10.1007/s13555-023-01064-1. PMID:38019410. IF:4.200(Q1/1D).